KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Retained Earnings (2019 - 2025)

Clover Health Investments' Retained Earnings history spans 7 years, with the latest figure at $528000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 133.33% year-over-year to $528000.0; the TTM value through Dec 2025 reached $528000.0, up 133.33%, while the annual FY2025 figure was $528000.0, 133.33% up from the prior year.
  • Retained Earnings reached $528000.0 in Q4 2025 per CLOV's latest filing, up from -$2.2 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $852000.0 in Q3 2024 to a low of -$2.2 billion in Q3 2025.
  • Average Retained Earnings over 5 years is -$890.5 million, with a median of -$4.9 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: crashed 16160250.0% in 2021, then skyrocketed 133.33% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$1.6 billion in 2021, then decreased by 20.45% to -$1.9 billion in 2022, then surged by 99.88% to -$2.4 million in 2023, then skyrocketed by 33.16% to -$1.6 million in 2024, then surged by 133.33% to $528000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Retained Earnings are $528000.0 (Q4 2025), -$2.2 billion (Q3 2025), and $177000.0 (Q2 2025).